Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Br J Cancer ; 111(3): 551-8, 2014 Jul 29.
Article in English | MEDLINE | ID: mdl-24937664

ABSTRACT

BACKGROUND: This study aimed to identify novel biomarkers for thyroid carcinoma diagnosis and prognosis. METHODS: We have constructed a human single-chain variable fragment (scFv) antibody library that was selected against tumour thyroid cells using the BRASIL method (biopanning and rapid analysis of selective interactive ligands) and phage display technology. RESULTS: One highly reactive clone, scFv-C1, with specific binding to papillary thyroid tumour proteins was confirmed by ELISA, which was further tested against a tissue microarray that comprised of 229 thyroid tissues, including: 110 carcinomas (38 papillary thyroid carcinomas (PTCs), 42 follicular carcinomas, 30 follicular variants of PTC), 18 normal thyroid tissues, 49 nodular goitres (NG) and 52 follicular adenomas. The scFv-C1 was able to distinguish carcinomas from benign lesions (P=0.0001) and reacted preferentially against T1 and T2 tumour stages (P=0.0108). We have further identified an OTU domain-containing protein 1, DUBA-7 deubiquitinating enzyme as the scFv-binding antigen using two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. CONCLUSIONS: The strategy of screening and identifying a cell-surface-binding antibody against thyroid tissues was highly effective and resulted in a useful biomarker that recognises malignancy among thyroid nodules and may help identify lower-risk cases that can benefit from less-aggressive management.


Subject(s)
Adenocarcinoma, Follicular/metabolism , Biomarkers, Tumor/metabolism , Carcinoma, Papillary/metabolism , Thyroid Neoplasms/metabolism , Ubiquitin-Specific Proteases/metabolism , Adenocarcinoma, Follicular/pathology , Biomarkers, Tumor/immunology , Carcinoma, Papillary/pathology , Cell Line, Tumor , Diagnosis, Differential , Enzyme-Linked Immunosorbent Assay , Humans , Immunoblotting , Peptide Library , Single-Chain Antibodies/chemistry , Thyroid Neoplasms/pathology , Ubiquitin-Specific Proteases/immunology
2.
J Appl Microbiol ; 116(5): 1322-33, 2014 May.
Article in English | MEDLINE | ID: mdl-24447276

ABSTRACT

AIMS: To use the phage display technique to develop peptides with the capability to neutralize the cytotoxicity induced by Stx1 and Stx2 toxins produced by Shiga toxin-producing Escherichia coli (STEC). METHODS AND RESULTS: The phage display technique permitted the development of three peptides, named PC7-12, P12-26 and PC7-30, which bind to the globotriaosylceramide (Gb3) receptor for Shiga toxins produced by STEC. Moreover, these peptides were capable of competing efficiently with the Shiga toxins for binding to Gb3. The peptides described herein partially inhibited the Stx-induced cytotoxicity of cell-free filtrates of STEC O157 : H7 and purified Stx toxins in Vero cells. The inhibition of lethality induced by Stx toxins in mice indicated that peptide PC7-30 inhibited the lethality caused by Stx1 (2LD50) in mice. CONCLUSIONS: The phage display technique permitted the development of peptides that inhibited the cytotoxicity induced by Stx toxins in vitro. Peptide PC7-30 inhibited the lethality of Stx1 in vivo; this molecule would be a promising candidate for the development of therapeutic agents for STEC-related diseases in humans. SIGNIFICANCE AND IMPACT OF THE STUDY: The selection of Gb3, the common receptor for Stx1 and Stx2, may contribute to the development of efficient neutralizers for both toxins, and our approach would be an interesting alternative for the development of therapeutic molecules for the treatment of diseases caused by STEC strains.


Subject(s)
Peptides/pharmacology , Shiga Toxin 1/antagonists & inhibitors , Shiga Toxin 2/antagonists & inhibitors , Animals , Chlorocebus aethiops , Humans , Mice , Peptide Library , Peptides/chemistry , Peptides/metabolism , Shiga Toxin 1/toxicity , Shiga Toxin 2/toxicity , Shiga-Toxigenic Escherichia coli/metabolism , Trihexosylceramides/metabolism , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...